These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

35 related articles for article (PubMed ID: 10840756)

  • 21. Measurement of phosphoinositide 3-kinase and its products to study adipogenic signal transduction.
    Sorisky A; Gagnon A
    Methods Mol Biol; 2008; 456():317-25. PubMed ID: 18516572
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Enzyme assays for protein kinase C activity.
    Sando JJ; Beals JK
    Methods Mol Biol; 2003; 233():63-76. PubMed ID: 12840498
    [No Abstract]   [Full Text] [Related]  

  • 23. Comparison of the kinetic properties of the lipid- and protein-kinase activities of the p110alpha and p110beta catalytic subunits of class-Ia phosphoinositide 3-kinases.
    Beeton CA; Chance EM; Foukas LC; Shepherd PR
    Biochem J; 2000 Sep; 350 Pt 2(Pt 2):353-9. PubMed ID: 10947948
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Role of PI3-kinase and PI4-kinase in actin polymerization during bovine sperm capacitation.
    Etkovitz N; Rubinstein S; Daniel L; Breitbart H
    Biol Reprod; 2007 Aug; 77(2):263-73. PubMed ID: 17494916
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Measurement of phosphoinositide 3-kinase activity.
    Ward SG
    Methods Mol Biol; 2000; 138():163-72. PubMed ID: 10840756
    [No Abstract]   [Full Text] [Related]  

  • 26. The role of phosphoinositide 3-kinase pathway inhibitors in the treatment of lung cancer.
    Engelman JA
    Clin Cancer Res; 2007 Aug; 13(15 Pt 2):s4637-40. PubMed ID: 17671156
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The phosphoinositide 3-kinase pathway and cancer.
    Stokoe D
    Expert Rev Mol Med; 2005 Jun; 7(10):1-22. PubMed ID: 15938760
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Class IA phosphoinositide 3-kinase isoforms and human tumorigenesis: implications for cancer drug discovery and development.
    Wee S; Lengauer C; Wiederschain D
    Curr Opin Oncol; 2008 Jan; 20(1):77-82. PubMed ID: 18043260
    [TBL] [Abstract][Full Text] [Related]  

  • 29.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 30.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 31.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 32.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 33.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 34.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 35.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]     [New Search]
    of 2.